Stock listing
A14QXP Stock Price, News, Filings & Events — Ose Immunotherapeutics Sa
Selected listing: A14QXP · LSX · EUR · DE
This page tracks Ose Immunotherapeutics Sa's A14QXP:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A14QXP:LSX. A14QXP:LSX is the stock-level entry point for investors researching Ose Immunotherapeutics Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A14QXP:LSX
- Asset type
- Stock
- Market cap
- $75.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSX
- Currency
- EUR
Ose Immunotherapeutics Sa A14QXP:LSX stock context
This page tracks Ose Immunotherapeutics Sa's A14QXP:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A14QXP:LSX. A14QXP:LSX is the stock-level entry point for investors researching Ose Immunotherapeutics Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Ose Immunotherapeutics Sa
OSE Immunotherapeutics Welcomes First Patient Dosed by Veloxis in the Phase 2 RENGEVITY-201 Trial Evaluating Pegrizeprument (VEL-101) for...
September 9, 2026
OSE Immunotherapeutics se félicite de l’inclusion du premier patient traité par Veloxis dans l’étude de phase 2 RENGEVITY-201 évaluant le...
September 8, 2026
Informations relatives au nombre total de droits de vote et d’actions composant le capital
September 6, 2026
OSE Immunotherapeutics to host a KOL webcast dedicated to lusvertikimab on September 2, 2026
August 27, 2026
Informations relatives au nombre total de droits de vote et d’actions composant le capital
August 25, 2026
Research Ose Immunotherapeutics Sa
Ose Immunotherapeutics Sa investor report
Review AI stock analysis and investor report context for A14QXP:LSX.
Ose Immunotherapeutics Sa company profile
View the public company page for Ose Immunotherapeutics Sa on 6ix.
Ose Immunotherapeutics Sa news
Read company news and market updates connected to Ose Immunotherapeutics Sa.
Ose Immunotherapeutics Sa investor events
Find investor webinars, events, and replay context for Ose Immunotherapeutics Sa.
Alternate listings
OSE:EURONEXT
FR · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is A14QXP:LSX.
0RAD:LSE
GB · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is A14QXP:LSX.
6OP:GETTEX
DE · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is A14QXP:LSX.
A14QXP:LS
DE · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is A14QXP:LSX.
6OP:TRADEGATE
DE · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is A14QXP:LSX.
OSEP:AQUISEU
GB · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is A14QXP:LSX.
6OP:MUN
DE · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is A14QXP:LSX.
ORPOF:OTC
US · USD
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is A14QXP:LSX.
OSEP:AQUISUK
GB · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is A14QXP:LSX.
6OP:DUS
DE · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is A14QXP:LSX.
6OP:FWB
DE · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is A14QXP:LSX.
6OP:HAM
DE · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is A14QXP:LSX.